Related Experiment Videos
Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies
1Department of Neurology, Ohio State University, Columbus.
Advances in Experimental Medicine and Biology
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis.
Neuromuscular disorders : NMD·2013
Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.
Molecular therapy : the journal of the American Society of Gene Therapy·2013
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Emerging biodegradable nanomaterials for innovative tumor immunotherapy.
Journal of materials chemistry. B·2026
The First Pan-African Survey of Interventional Pulmonology: Current Practice, Training Gaps, and Barriers.
Journal of bronchology & interventional pulmonology·2026
Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide.
Journal of inflammation research·2026
Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.
ESMO gastrointestinal oncology·2026